NEW YORK (GenomeWeb) – Bruker reported after the close of the market Tuesday that its second quarter revenues were down 6 percent year over year, and down more than 9 percent excluding the effect of acquisitions.

For the three months ended June 30, Billerica, Massachusetts-based Bruker reported revenues of $371.7 million, compared to $396.0 million in Q2 2015.

Changes in foreign exchange rates did not impact the company's revenues. The results came in below the average Wall Street estimate of $410.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.